Lung abscess medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Lung abscess}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Overview=...") |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lung abscess}} | {{Lung abscess}} | ||
{{CMG}} | {{CMG}};{{AE}}{{ADG}} | ||
==Overview== | |||
==Medical Therapy== | |||
*The mainstay of management for lung abscess is: hospital admission for chest drain and systemic antibiotics.<ref name="pmid14759242">{{cite journal |vauthors=Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H |title=Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess |journal=Clin. Microbiol. Infect. |volume=10 |issue=2 |pages=163–70 |year=2004 |pmid=14759242 |doi= |url=}}</ref> | |||
*Empiric treatment should be commenced after culture samples are obtained. | |||
*The choice of empiric antibiotics should be determined on the basis of the possible risk of multi-drug resistant causative bacteria, and culture results. | |||
The following table summarizes the treatment for Lung abscess | |||
== | {| class="wikitable" | ||
! colspan="2" rowspan="2" |Pathogens | |||
!Age group specific therapy | |||
|- | |||
!Adult | |||
|- | |||
| rowspan="2" |Empiric | |||
|Anaerobes and microaerophilic streptococci | |||
|· Ampicillin +sulbactum 3g IV q6h<ref name="pmid8296141">{{cite journal |vauthors=Germaud P, Poirier J, Jacqueme P, Guerin JC, Benard Y, Boutin C, Brambilla C, Escamilla R, Zuck P |title=[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases] |language=French |journal=Rev Pneumol Clin |volume=49 |issue=3 |pages=137–41 |year=1993 |pmid=8296141 |doi= |url=}}</ref> | |||
(or) | |||
· Imipenem+cilastin 500 mg IV q6h | |||
(or) | |||
== | · Meropenem 1-2 g IV q8h | ||
|- | |||
| Alternnative<ref name="pmid6838068">{{cite journal |vauthors=Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR |title=Clindamycin compared with penicillin for the treatment of anaerobic lung abscess |journal=Ann. Intern. Med. |volume=98 |issue=4 |pages=466–71 |year=1983 |pmid=6838068 |doi= |url=}}</ref> | |||
|Clindamycin IV 600 mg q8h | |||
150 to 300 mg orally four times daily | |||
|- | |||
| rowspan="6" |Pathogen directed | |||
|[[MSSA]] | |||
|[[Nafcillin]] 2 g IV q4h <u>'''OR'''</u> [[Oxacillin]] 2 g IV q4h '''<u>OR</u>''' [[Cefazolin]] 2 g IV q8h | |||
|- | |||
|[[MRSA]] | |||
|[[Linezolid]] 600 mg q12h IV/PO ± [[Rifampin]] 300 mg po/IV bid <ref name="pmid20206987">{{cite journal |vauthors=DeLeo FR, Otto M, Kreiswirth BN, Chambers HF |title=Community-associated meticillin-resistant Staphylococcus aureus |journal=Lancet |volume=375 |is<ref name="WunderinkNiederman2012">{{cite journal|last1=Wunderink|first1=R. G.|last2=Niederman|first2=M. S.|last3=Kollef|first3=M. H.|last4=Shorr|first4=A. F.|last5=Kunkel|first5=M. J.|last6=Baruch|first6=A.|last7=McGee|first7=W. T.|last8=Reisman|first8=A.|last9=Chastre|first9=J.|title=Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study|journal=Clinical Infectious Diseases|volume=54|issue=5|year=2012|pages=621–629|issn=1058-4838|doi=10.1093/cid/cir895}}</ref>sue=9725 |pages=1557–68 |year=2010 |pmid=20206987 |pmc=3511788 |doi=10.1016/S0140-6736(09)61999-1 |url=}}</ref> | |||
|- | |||
|Actinomyces | |||
|Intravenous penicillin G (10 to 20 million units daily in divided doses every four to six hours) for 4 to 6 weeks, | |||
|- | |||
|Nocardia .spp | |||
|TMP-SMX 15 mg/kg IV of the trimethoprim component per day in three or four divided doses | |||
'''PLUS''' | |||
Amikacin 7.5 mg/kg IV every 12 hours | |||
|- | |||
|Fungi | |||
|Amphotericin B 3-5mg/kg/day/IV | |||
|- | |||
|Parasite | |||
|Albendazole is dosed 10 to 15 mg/kg per day in two divided doses; the usual dose for adults is 400 mg twice daily. | |||
one to three months may be a | |||
ppropriate, depending clinical factors; up to six months may be required. | |||
|} | |||
*Clinical improvement is reflected in the subsidence of fever (within the first 3-4 days) and complete defervescence within 7-10 days.Persistent fever can be explained by treatment failure due to uncommon pathogens (multidrug resistant common bacteria, mycobacteria, fungi)or by the presence of an alternative diagnosis (e.g. endobronchial obstruction, vasculitis) that requires further diagnostic workup (e.g. bronchoscopy, transdermal or surgical lung biopsy).<ref name="pmid20389050">{{cite journal |vauthors=Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y |title=Etiology and outcome of community-acquired lung abscess |journal=Respiration |volume=80 |issue=2 |pages=98–105 |year=2010 |pmid=20389050 |doi=10.1159/000312404 |url=}}</ref> | |||
*The duration of treatment with antibiotics is not well defined, according to many experts, the optimal duration of antimicrobial therapy is 3-6 weeks, whereas others take the timing of radiological response into consideration. <ref name="pmid20389050">{{cite journal |vauthors=Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y |title=Etiology and outcome of community-acquired lung abscess |journal=Respiration |volume=80 |issue=2 |pages=98–105 |year=2010 |pmid=20389050 |doi=10.1159/000312404 |url=}}</ref> | |||
*In that case, the length of antibiotic treatment depends on complete radiological resolution or stabilization to a small residual lesion. | |||
*Treatment interval may then be prolonged to several months (more than 2),6 especially when the initial lesion is of large size (maximum diameter more than 6cm). | |||
== Reference == | == Reference == | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 17:28, 3 February 2017
Lung abscess Microchapters |
Diagnosis |
Treatment |
Case Studies |
Lung abscess medical therapy On the Web |
American Roentgen Ray Society Images of Lung abscess medical therapy |
Risk calculators and risk factors for Lung abscess medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Medical Therapy
- The mainstay of management for lung abscess is: hospital admission for chest drain and systemic antibiotics.[1]
- Empiric treatment should be commenced after culture samples are obtained.
- The choice of empiric antibiotics should be determined on the basis of the possible risk of multi-drug resistant causative bacteria, and culture results.
The following table summarizes the treatment for Lung abscess
Pathogens | Age group specific therapy | |
---|---|---|
Adult | ||
Empiric | Anaerobes and microaerophilic streptococci | · Ampicillin +sulbactum 3g IV q6h[2]
(or) · Imipenem+cilastin 500 mg IV q6h (or) · Meropenem 1-2 g IV q8h |
Alternnative[3] | Clindamycin IV 600 mg q8h
150 to 300 mg orally four times daily | |
Pathogen directed | MSSA | Nafcillin 2 g IV q4h OR Oxacillin 2 g IV q4h OR Cefazolin 2 g IV q8h |
MRSA | Linezolid 600 mg q12h IV/PO ± Rifampin 300 mg po/IV bid sue=9725 |pages=1557–68 |year=2010 |pmid=20206987 |pmc=3511788 |doi=10.1016/S0140-6736(09)61999-1 |url=}}</ref> | |
Actinomyces | Intravenous penicillin G (10 to 20 million units daily in divided doses every four to six hours) for 4 to 6 weeks, | |
Nocardia .spp | TMP-SMX 15 mg/kg IV of the trimethoprim component per day in three or four divided doses
PLUS Amikacin 7.5 mg/kg IV every 12 hours | |
Fungi | Amphotericin B 3-5mg/kg/day/IV | |
Parasite | Albendazole is dosed 10 to 15 mg/kg per day in two divided doses; the usual dose for adults is 400 mg twice daily.
one to three months may be a ppropriate, depending clinical factors; up to six months may be required. |
- Clinical improvement is reflected in the subsidence of fever (within the first 3-4 days) and complete defervescence within 7-10 days.Persistent fever can be explained by treatment failure due to uncommon pathogens (multidrug resistant common bacteria, mycobacteria, fungi)or by the presence of an alternative diagnosis (e.g. endobronchial obstruction, vasculitis) that requires further diagnostic workup (e.g. bronchoscopy, transdermal or surgical lung biopsy).[4]
- The duration of treatment with antibiotics is not well defined, according to many experts, the optimal duration of antimicrobial therapy is 3-6 weeks, whereas others take the timing of radiological response into consideration. [4]
- In that case, the length of antibiotic treatment depends on complete radiological resolution or stabilization to a small residual lesion.
- Treatment interval may then be prolonged to several months (more than 2),6 especially when the initial lesion is of large size (maximum diameter more than 6cm).
Reference
- ↑ Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H (2004). "Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess". Clin. Microbiol. Infect. 10 (2): 163–70. PMID 14759242.
- ↑ Germaud P, Poirier J, Jacqueme P, Guerin JC, Benard Y, Boutin C, Brambilla C, Escamilla R, Zuck P (1993). "[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases]". Rev Pneumol Clin (in French). 49 (3): 137–41. PMID 8296141.
- ↑ Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR (1983). "Clindamycin compared with penicillin for the treatment of anaerobic lung abscess". Ann. Intern. Med. 98 (4): 466–71. PMID 6838068.
- ↑ 4.0 4.1 Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y (2010). "Etiology and outcome of community-acquired lung abscess". Respiration. 80 (2): 98–105. doi:10.1159/000312404. PMID 20389050.